Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00254488 · ClinicalTrials.gov registry record · Phase 4
Treatment of Bipolar Mania in Older Adults
A Phase 4 study of Bipolar Disorder and Mania, sponsored by Weill Medical College of Cornell University.
- Completed
- Registry status
- Phase 4
- Development phase
- 224
- Enrollment target
- 8
- Study locations
NCT00254488 is a Phase 4 study of Bipolar Disorder and Mania that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 224 participants, below the 331-participant average among 162 other Bipolar Disorder trials with a reported enrollment target (32% lower). The trial reports 8 study locations across 7 states.
The verdict
NCT00254488, a Phase 4 study of Bipolar Disorder and Mania, has completed, sponsored by Weill Medical College of Cornell University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 224 participants
- Enrollment target
- 8
- Study locations
Study Summary
This study will compare the benefits and side effects of lithium and divalproex in the treatment of older adults with bipolar mania.
Conditions Studied
Interventions
- DRUG Lithium (LI)
- DRUG Divalproex (DV)
Study Locations (8)
Pennsylvania
- University of Pennsylvania - Philadelphia
- University of Pittsburgh - Pittsburgh
Mississippi
- Precise Research Centers - Flowood
New York
- Weill Cornell Medical College - White Plains
North Carolina
- Duke University Medical Center - Durham
Ohio
- University Hospitals Case Medical Center - Cleveland
Texas
- Baylor College of Medicine - Houston
Ontario
- Centre for Addiction and Mental Health - Toronto
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 224 participants |
| Start Date | 2005-11 |
| Est. Completion | 2011-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00254488
The ClinicalTrials.gov registry entry for NCT00254488 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 224 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 331-participant average among 162 other Bipolar Disorder trials with a reported enrollment target (32% lower). The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Bipolar Disorder appearing as the primary indexed condition, and to 2 interventions - of which Lithium (LI) is the first listed.
NCT00254488 reports 8 study locations spanning 7 distinct geographic areas - top geographies include Pennsylvania, Mississippi, New York.
Frequently Asked Questions
What is clinical trial NCT00254488 about?
NCT00254488 is a clinical study titled "Treatment of Bipolar Mania in Older Adults". This study will compare the benefits and side effects of lithium and divalproex in the treatment of older adults with bipolar mania.
What is the current status of trial NCT00254488?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 224 participants. The study started on 2005-11. Estimated completion is 2011-08.
What conditions does trial NCT00254488 study?
This clinical trial studies the following conditions: Bipolar Disorder, Mania.
What interventions are being tested in trial NCT00254488?
The interventions under investigation include: Lithium (LI) (DRUG), Divalproex (DV) (DRUG).
Who is sponsoring clinical trial NCT00254488?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00254488 being conducted?
This trial has 8 study locations across Mississippi, New York, North Carolina, Ohio, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bipolar Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
RECRUITING · Phase 4
-
FMRI Study of Brain Response Before and After Lithium Treatment in People With Bipolar Disorder
COMPLETED · Phase 4
-
Treatment of Geriatric Bipolar Mood Disorders: A Pilot Study
COMPLETED · Phase 4
-
Treatment With Quetiapine for Youth With Substance Use Disorders and Severe Mood Dysregulation
COMPLETED · Phase 4
-
Quetiapine in Patients With Bipolar and Alcohol Abuse/Dependence
COMPLETED · Phase 4
-
Lamictal As Add on Treatment in Mixed States of Bipolar Disorder
COMPLETED · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.